linalool has been researched along with Epithelial Ovarian Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Han, HD; Kang, TH; Lee, CM; Lee, JW; Park, YM; Shin, BC; Wi, TI; Won, JE | 1 |
Bae, DS; Byeon, Y; Cho, SK; Cho, YJ; Han, HD; Jeon, HN; Kim, BG; Kim, HS; Lee, JW; Lopez-Berestein, G; Park, YM; Shin, BC; Sood, AK | 1 |
2 other study(ies) available for linalool and Epithelial Ovarian Cancer
Article | Year |
---|---|
Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.
Topics: Acyclic Monoterpenes; Animals; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Doxorubicin; Drug Carriers; Emulsions; Female; Humans; Liposomes; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Particle Size; Polyethylene Glycols; Treatment Outcome | 2020 |
Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma.
Topics: Acyclic Monoterpenes; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Membrane Potential, Mitochondrial; Mice; Monoterpenes; Nanoparticles; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Reactive Oxygen Species; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |